Marine Serri

Odilorhabdins, Antibacterial Agents that Cause Miscoding by Binding at a New Ribosomal Site

Lucile Pantel, Tanja Florin, Malgorzata Dobosz-Bartoszek et al. · Molecular Cell · 2018 · 139 citations · Full text

Life Sciences, Microbiology, Molecular Biology +12

Total Synthesis and Structure–Activity Relationships Study of Odilorhabdins, a New Class of Peptides Showing Potent Antibacterial Activity

Matthieu Sarciaux, Lucile Pantel, Camille Midrier et al. · Journal of Medicinal Chemistry · 2018 · 29 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

<i>In Vitro</i> and <i>In Vivo</i> Characterization of NOSO-502, a Novel Inhibitor of Bacterial Translation

Emilie Racine, Patrice Nordmann, Lucile Pantel et al. · Antimicrobial Agents and Chemotherapy · 2018 · 28 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Exploring Cluster-Dependent Antibacterial Activities and Resistance Pathways of NOSO-502 and Colistin against Enterobacter cloacae Complex Species

Lucile Pantel, François Guérin, Marine Serri et al. · Antimicrobial Agents and Chemotherapy · 2022 · 17 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +9

Missense Mutations in the CrrB Protein Mediate Odilorhabdin Derivative Resistance in Klebsiella pneumoniae

Lucile Pantel, Paulo Juarez, Marine Serri et al. · Antimicrobial Agents and Chemotherapy · 2021 · 16 citations · Full text

Life Sciences, Microbiology, Pharmacology +14